Logo image of RVP

RETRACTABLE TECHNOLOGIES INC (RVP) Stock Fundamental Analysis

NYSEARCA:RVP - NYSE Arca - US76129W1053 - Common Stock - Currency: USD

0.846  +0.02 (+1.93%)

After market: 0.84 -0.01 (-0.71%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RVP. RVP was compared to 190 industry peers in the Health Care Equipment & Supplies industry. RVP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RVP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RVP has reported negative net income.
In the past year RVP has reported a negative cash flow from operations.
RVP had positive earnings in 4 of the past 5 years.
Each year in the past 5 years RVP had a positive operating cash flow.
RVP Yearly Net Income VS EBIT VS OCF VS FCFRVP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

RVP's Return On Assets of -10.11% is in line compared to the rest of the industry. RVP outperforms 59.57% of its industry peers.
With a decent Return On Equity value of -19.12%, RVP is doing good in the industry, outperforming 60.64% of the companies in the same industry.
Industry RankSector Rank
ROA -10.11%
ROE -19.12%
ROIC N/A
ROA(3y)8.49%
ROA(5y)11.39%
ROE(3y)17.82%
ROE(5y)23.04%
ROIC(3y)N/A
ROIC(5y)N/A
RVP Yearly ROA, ROE, ROICRVP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

Looking at the Gross Margin, with a value of 7.86%, RVP is doing worse than 82.98% of the companies in the same industry.
RVP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RVP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.67%
GM growth 5Y-7.37%
RVP Yearly Profit, Operating, Gross MarginsRVP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

RVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RVP has about the same amount of shares outstanding.
The number of shares outstanding for RVP has been reduced compared to 5 years ago.
The debt/assets ratio for RVP has been reduced compared to a year ago.
RVP Yearly Shares OutstandingRVP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
RVP Yearly Total Debt VS Total AssetsRVP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

RVP has an Altman-Z score of 0.76. This is a bad value and indicates that RVP is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.76, RVP perfoms like the industry average, outperforming 47.87% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that RVP is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.01, RVP is doing good in the industry, outperforming 67.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.76
ROIC/WACCN/A
WACC8.99%
RVP Yearly LT Debt VS Equity VS FCFRVP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

RVP has a Current Ratio of 8.57. This indicates that RVP is financially healthy and has no problem in meeting its short term obligations.
RVP has a Current ratio of 8.57. This is amongst the best in the industry. RVP outperforms 90.96% of its industry peers.
RVP has a Quick Ratio of 5.92. This indicates that RVP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.92, RVP belongs to the top of the industry, outperforming 86.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.57
Quick Ratio 5.92
RVP Yearly Current Assets VS Current LiabilitesRVP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

RVP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.09%.
The Revenue has decreased by -8.87% in the past year.
RVP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.54% yearly.
EPS 1Y (TTM)-44.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.76%
Revenue 1Y (TTM)-8.87%
Revenue growth 3Y-18.96%
Revenue growth 5Y5.54%
Sales Q2Q%0.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RVP Yearly Revenue VS EstimatesRVP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
RVP Yearly EPS VS EstimatesRVP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RVP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RVP Price Earnings VS Forward Price EarningsRVP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RVP Per share dataRVP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RVP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RETRACTABLE TECHNOLOGIES INC

NYSEARCA:RVP (2/21/2025, 8:04:00 PM)

After market: 0.84 -0.01 (-0.71%)

0.846

+0.02 (+1.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12
Earnings (Next)03-27 2025-03-27
Inst Owners7.61%
Inst Owner Change-86.97%
Ins Owners56.75%
Ins Owner Change3.14%
Market Cap25.33M
Analysts0
Price TargetN/A
Short Float %0.21%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)3.09%
DP-1.47%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS1.28
BVpS2.79
TBVpS2.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.11%
ROE -19.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.86%
FCFM N/A
ROA(3y)8.49%
ROA(5y)11.39%
ROE(3y)17.82%
ROE(5y)23.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.67%
GM growth 5Y-7.37%
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.54%
Cap/Sales 3.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.57
Quick Ratio 5.92
Altman-Z 0.76
F-Score4
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)1669.91%
Cap/Depr(5y)1524%
Cap/Sales(3y)16.9%
Cap/Sales(5y)15.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.87%
Revenue growth 3Y-18.96%
Revenue growth 5Y5.54%
Sales Q2Q%0.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.28%
OCF growth 3Y-47.39%
OCF growth 5YN/A